Blood Pressure Polygenic Scores Are Associated With Apparent Treatment-Resistant Hypertension.
作者信息
Breeyear Joseph H, Shuey Megan M, Edwards Todd L, Hellwege Jacklyn N
机构信息
Vanderbilt Genetics Institute (J.H.B., M.M.S., T.L.E., J.N.H.), Vanderbilt University Medical Center, Nashville, TN.
Division of Genetic Medicine, Department of Medicine (M.M.S., J.N.H.), Vanderbilt University Medical Center, Nashville, TN.
出版信息
Circ Genom Precis Med. 2022 Jun;15(3):e003554. doi: 10.1161/CIRCGEN.121.003554. Epub 2022 May 6.
Abstract
摘要
相似文献
1
Blood Pressure Polygenic Scores Are Associated With Apparent Treatment-Resistant Hypertension.血压多基因评分与明显的难治性高血压相关。
Circ Genom Precis Med. 2022 Jun;15(3):e003554. doi: 10.1161/CIRCGEN.121.003554. Epub 2022 May 6.
2
Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.鉴定与相关表型相关的血压多基因多效性中的常见遗传变异。
Hypertension. 2014 Apr;63(4):819-26. doi: 10.1161/HYPERTENSIONAHA.113.02077. Epub 2014 Jan 6.
3
Are minor gene effects of clinical importance?具有临床重要性的微小基因效应存在吗？
J Hypertens. 2007 Mar;25(3):505-7. doi: 10.1097/HJH.0b013e32805aed07.
4
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy.利用基因组学开发新型治疗方法并实现高血压治疗的个体化。
Arterioscler Thromb Vasc Biol. 2024 Apr;44(4):784-793. doi: 10.1161/ATVBAHA.123.319220. Epub 2024 Feb 22.
5
Genetic mechanisms of human hypertension and their implications for blood pressure physiology.人类高血压的遗传机制及其对血压生理学的影响。
Physiol Genomics. 2017 Nov 1;49(11):630-652. doi: 10.1152/physiolgenomics.00032.2017. Epub 2017 Sep 8.
6
The future of pharmacogenetics in the treatment of hypertension.药物遗传学在高血压治疗中的未来。
Pharmacogenomics. 2019 Feb;20(3):129-132. doi: 10.2217/pgs-2018-0191. Epub 2019 Feb 27.
7
The multifactorial nature of hypertension: the greatest challenge for its treatment?高血压的多因素性质：其治疗面临的最大挑战？
J Hypertens Suppl. 2001 Sep;19(3):S9-16.
8
Use of gene markers to guide antihypertensive therapy.使用基因标志物指导抗高血压治疗。
Curr Hypertens Rep. 2001 Oct;3(5):410-5. doi: 10.1007/s11906-001-0059-x.
9
Pharmacogenomics of antihypertensive drugs: past, present and future.降压药物的药物基因组学：过去、现在和未来。
Pharmacogenomics. 2010 Apr;11(4):487-91. doi: 10.2217/pgs.10.34.
10
Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses.原发性高血压的多基因风险评分与降压药物反应无显著相关性。
Sci Rep. 2020 Jul 20;10(1):11940. doi: 10.1038/s41598-020-68878-3.
引用本文的文献
1
Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response.收缩压多基因风险评分与氯噻酮反应的效用。
JAMA Cardiol. 2024 Dec 1;9(12):1134-1141. doi: 10.1001/jamacardio.2024.3649.
2
Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.多基因背景对家族性高胆固醇血症临床表现的影响。
Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1683-1693. doi: 10.1161/ATVBAHA.123.320287. Epub 2024 May 23.
本文引用的文献
1
Polygenic prediction via Bayesian regression and continuous shrinkage priors.基于贝叶斯回归和连续收缩先验的多基因预测。
Nat Commun. 2019 Apr 16;10(1):1776. doi: 10.1038/s41467-019-09718-5.
2
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.超过 75 万人的血压决定因素的跨种族关联研究。
Nat Genet. 2019 Jan;51(1):51-62. doi: 10.1038/s41588-018-0303-9. Epub 2018 Dec 21.
3
Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case-control study.采用电子健康记录识别出的学术医疗中心中具有抗药性高血压的非裔美国人和欧裔美国患者的特征和治疗：一项病例对照研究。
BMJ Open. 2018 Jun 27;8(6):e021640. doi: 10.1136/bmjopen-2018-021640.
4
Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.单性状和多性状全基因组关联分析确定了非洲裔人群中血压的新基因座。
PLoS Genet. 2017 May 12;13(5):e1006728. doi: 10.1371/journal.pgen.1006728. eCollection 2017 May.
5
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.貌似难治性高血压与中风、冠心病及全因死亡率风险
J Am Soc Hypertens. 2014 Jun;8(6):405-13. doi: 10.1016/j.jash.2014.03.003. Epub 2014 Mar 15.
Zotero 插件